Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes-Reference-Cited by-同舟云学术

Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes

Published:2024-05 Issue:5 Volume:42 Page:732-735
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Saliby Renée Maria,Labaki Chris,Jammihal Tejas R.,Xie Wanling,Sun Maxine,Shah Valisha,Saad Eddy,Kane M. Harry,Kashima Soki,Sadak Katherine,El Zarif Talal,Poduval Deepak,Motzer Robert J.,Powles Thomas,Rini Brian I.,Albiges Laurence,Pal Sumanta K.,McGregor Bradley A.,McKay Rana R.,Signoretti Sabina,Van Allen Eliezer M.,Shukla Sachet A.,Choueiri Toni K.,Braun David A.

Publisher

Elsevier BV

Reference6 articles.

1. The Changing Landscape of Immunotherapy for Advanced Renal Cancer;Kashima;Urol. Clin.,2023

2. Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade;Motzer;Cancer Cell,2020

3. Optimal treatment by invoking biologic clusters in renal cell carcinoma (OPTIC RCC);Chen;J. Clin. Oncol.,2023

4. Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma;Choueiri;Ann. Oncol.,2020

5. Molecular alterations across sites of metastasis in patients with renal cell carcinoma (RCC);McKay;J. Clin. Oncol.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heritable and spatial immunogenic traits co-predict the efficacy of immunotherapy in kidney cancer;Nature Medicine;2024-06

2. Une nouvelle place pour les biomarqueurs circulants dans le cancer du rein en 2024 ?;Bulletin du Cancer;2024-06

3. Molecular subtypes as potential biomarkers in renal cell carcinoma;Cancer Cell;2024-05